Researchers found that one mosquito-borne virus automatically targets and kills tumor cells in mice. Most importantly, it does so while leaving healthy cells alone, a feature that may make it promising treatment for some forms of cancer.
Scientists have identified a gene in the cerebral cortex that apparently controls the developmental clock of embryonic nerve cells, a finding that could open another door to tissue replacement therapy in the central nervous system.
Media Advisory offering a urologist as an expert to comment on an important embargoed study.
Researchers have found that people living in U.S. cities face an increased risk of dying from a heart attack as a result of long-term exposure to air pollution. This increased risk was found to be as large as that associated with being a former smoker.
Using a new technique to measure the volume of the brain, researchers were able to identify healthy individuals who would later develop memory impairment, a symptom associated with a high risk for future Alzheimer's disease.
New York University School of Medicine's Institute for Urban and Global Health received a $5 million grant from the National Institutes of Health to establish the nation's first Center for the Study of Asian American Health.
On October 14th, the first patient will be vaccinated in a clinical trial of a new cancer vaccine. The vaccine is designed to prevent patients who have already had a kind of cancer called follicular lymphoma from having a recurrence of the disease.
A 7-Tesla MRI (magnetic resonance imaging) machine will be in operation in 2004 at the School of Medicine. It will be the most powerful MRI machine in the New York metropolitan area and one of only a handful of such big magnets available for clinical and basic research in the United States.
If the immune system had a motto, new research shows that an appropriate one would be "No job too big or too small." A multi-center team has found that the system can respond to infections that range from sneak attacks to all-out onslaughts thanks to a doughnut-shaped molecular structure.
Lenard Adler, M.D., an expert in adult ADHD at New York University School of Medicine is available to comment on an article in the Journal of the American Medical Association (embargoed: 9/23 4PM), "ADHD Often Undiagnosed in Adults: Appropriate Treatment May Benefit Work, Family, Social Life."
An epilepsy drug used in Europe and elsewhere can stop cocaine use in hard-core addicts, in part by eliminating their craving for cocaine, according to the first study to assess the treatment's effects on addicts.
The Hopi Foundation announced today that Allen Keller, M.D., Founder and Director of the NYU/Bellevue Survivor's of Torture Program in New York, has been selected to receive the 2003 Barbara Chester Award for clinicians/practitioners working with survivors of torture.
In a new study, NYU School of Medicine researchers have found what may be an Achilles' heel of deadly anthrax -- a system that the bacteria use to communicate their presence to others of their kind.
Inadequate clinical training, inexperience and the lack of a well-validated screening tool are major barriers prohibiting primary care physicians from diagnosing ADHD in adults, according to a national survey. The survey also revealed that primary care physicians would take a more active role in treating adult ADHD if these issues were addressed.
Restylane provides safe and effective correction of nasolabial folds and longer-lasting results than Zyplast. Restylane is currently under review by the FDA to receive marketing approval for the treatment of facial lines, wrinkles and folds.
A new groundbreaking report by Physicians for Human Rights and the Bellevue/NYU Program for Survivors of Torture documents the harmful impact of imprisonment on the health and well being of asylum seekers.
Infectious Disease experts at NYU Medical Center are available to speak about the current monkeypox outbreak in the United States.
A new antibiotic appears effective against deadly strains of tuberculosis resistant to nearly all currently available treatments for the infectious disease, according to a report by physicians at NYU School of Medicine.
J. Thomas Roland, MD, Director of Otology and Neurotology at NYU Medical Center will implant an improved cochlear device, the first to be done on the East Coast, on Wednesday, May 14 and will perform the same surgery on a second patient on May 15.
NYU Medical Center's cardiac surgeons announced new study findings demonstrating significantly lowered mortality, stroke, and overall risk of complications using off-pump coronary artery by-pass grafting in high-risk patients.
A drug that quashes the activity of a key brain chemical is the first effective treatment for patients in the later stages of Alzheimer's disease, according to the results of a large multi-center clinical study.
NYU Medical Center experts available to speak on emergency preparedness and the medical consequences of war, bio-terrorism and torture.
In a finding that may open a new avenue to treating diabetes, researchers show that cells from the bone marrow give rise to insulin-producing cells in the pancreas of mice.
The NYU Comprehensive Epilepsy Center in partnership with The Epilepsy Institute and The Epilepsy Foundations of New Jersey, New York City, Southern New York, and Connecticut will present 3 simultaneous conferences focused on the recent developments in epilepsy treatment.
Dr. Ifeoma Okoronkwo, M.D., an expert in rehabilitation medicine at NYU Medical Center is available to comment on new findings that Botox can be used to treat chronic pain such as migraine headaches.
Allen Keller, MD, an international expert in the evaluation and treatment of torture victims, is available to speak on the controversy surrounding the treatment of suspected terrorists.
NYU Medical Center experts available to speak about war-related topics.
NYU Medical Center expert available to comment on epilepsy surgery "Treatment of Last Resort" considered to be most effective.
The Center for Global Health at NYU School of Medicine in collaboration with the International Health Medical Consortium has organized NYU's first International Health Day. The program features experts in global health from around the world.
1) how to stay healthy during the high- allergy season, 2) how to deal with the new found pressures of Spring, 3) germ hot spots, 4) when to see an fertility specialist, 5) healthy weight loss, and others.
An expert in pediatric cardiac surgery at NYU Medical Center is available to comment on a new study that infants and young children with heart defects benefited from a milrinone, a drug they received shortly after cardiac surgery.
NYU Medical Center recently received a $10 million gift from author, television producer and moderator, attorney, and real estate developer Leon H. Charney to bolster cardiac and vascular medicine at NYU Medical Center.
An inability to quickly bring down high levels of sugar in the blood is associated with poor memory and may help explain some of the memory loss that occurs as we age, according to a new study by NYU School of Medicine researchers.
Results of a new survey released today by the New York University Child Study Center show that there is an extraordinary crisis of untreated depression and anxiety among American adolescents, particularly adolescent girls.
New research is helping to provide an answer to the medical mystery of Down syndrome, the most common genetic cause of mental retardation. In a new study, researchers identify genes that may contribute to Down syndrome.
Researchers have identified a potential biomolecular marker for melanoma, the most serious form of skin cancer. In a new study, they report that the marker, a kind of molecular signature, may help identify people with melanoma who have a better prognosis.
Speak with NYU School of Medicine's academic researchers for tips on how to beat out winter sickness. Our clinicians can give various ways to stay healthy and happy during this winter season.
Only 20 years ago scientists first identified the bacterium Helicobacter pylori in the stomach, but it is has been on the planet far longer. A new study analyzing the distribution of certain genes in the bacterium shows that humans have been carrying it for at least 11,000 years.
NYU School of Medicine researchers report that a chemical in cigarette smoke causes mutations in a gene called RAS that are commonly associated with many human cancers, according to a new study.
Although children with attention-deficit/hyperactivity disorder (ADHD) have slightly smaller brains than children without the disorder, medications used to treat ADHD aren't causing this apparent difference in brain size and do not appear to be affecting normal brain development, according to the large brain imaging study led by an NYU School of Medicine researcher.
Scientists at NYU School of Medicine have for the first time identified genes in mosquitoes that reduce the natural transmission of the most lethal malaria parasite. Their findings potentially open new avenues to preventing malaria, one of the world's greatest scourges.
NYU Medical Center's Chief of Cardiothoracic Surgery, Stephen Colvin, MD, and Eugene Grossi, MD, Director of the Cardiac Surgical Research Laboratory announced today a major advance in medical animation technology with the creation of a three dimensional, animated beating heart.
Speak with NYU School of Medicine academic researchers as they investigate the physical and psychological impact on the citizens of New York City. Alternatively, our clinicians can recount various ways NYU Medical Center has responded to the disaster.
NYU Physicians hold forum to answer patients' questions about the benefits and risks of hormone replacement therapy.
New York University School of Medicine oncologist, Acting Chairman of the Department of Obstetrics and Gynecology, Director of the Division of Gynecologic Oncology, and a specialist in ovarian cancer, will be available to comment to the press regarding an important study showing a significantly increased risk of developing ovarian cancer with prolonged, meaning more than 10 years, use of estrogen-only hormone replacement therapy.
Scientists report that the toxic shock toxin, produced by the notorious bacterium Staphylococcus aureus, acts as a sort of master switch that blocks the infecting bacterium's production of most of its other disease-causing proteins.
Immunization with a non-toxic genetically engineered prion, a protein that causes a group of fatal brain diseases, including mad cow disease, delayed the onset of brain disease in mice, according to a preliminary study by NYU School of Medicine researchers and colleagues.
An epidemiological study published earlier this week by NYU School of Medicine researchers shows an association between regular use of aspirin and reduced risk of a common type of lung cancer in women. But the NYU researchers emphasized today that until large clinical trials establish aspirin's beneficial effect, women shouldn't start taking the painkiller to prevent cancer.
NYU Medical Center announced that it has entered into a strategic alliance with Siemens Medical Solutions USA, Inc., designed to establish the academic medical center as one of the nation's preeminent institutions for imaging in clinical care and scientific research.
NYU Medical Center is pleased to announce the opening on May 7th of the NYU Tuberous Sclerosis Center, the only designated center of its kind in the tri-state area. May is Tuberous Sclerosis Awareness Month. Tuberous Sclerosis is a genetic disease estimated to affect over 50,000 Americans and 1 million individuals worldwide.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right